MiR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer

Medical Oncology

Volumn 30, Issue 1, 2013, Pages

  Li, Bi Lan ^a   Lu, Cong ^b   Lu, Wen ^a   Yang, Ting Ting ^a   Qu, Junjie ^a   Hong, Xiayu ^a   Wan, Xiao Ping ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

DICER1; Endometrial cancer; Epithelial mesenchymal transition; miRNAs

Indexed keywords

DICER; DICER1; MICRORNA; MICRORNA 130B; UNCLASSIFIED DRUG; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; MATRIX METALLOPROTEINASE; MIRN130 MICRORNA, HUMAN; RIBONUCLEASE III;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; ENDOMETRIUM CANCER; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; TUMOR INVASION; ANIMAL; BAGG ALBINO MOUSE; DRUG SCREENING; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MOUSE; PATHOLOGY; REFERENCE VALUE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; ENDOMETRIAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICRORNAS; MIDDLE AGED; REFERENCE VALUES; RIBONUCLEASE III; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84873386731     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0484-0     Document Type: Article

References (21)

1. Azueta A, Gatius S, Matias-Guiu X. Endometrioid carcinoma of the endometrium: pathologic and molecular features. Semin Diagn Pathol. 2010;27:226-40.
2. Dedes KJ, Wetterskog D, Ashworth A, Kaye SB, Reis-Filho JS. Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol. 2011;8:261-71.
3. Chaudhry P, Asselin E. Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer. 2009;16:363-80.
4. Hammond SM. Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett. 2005;579:5822-9.
5. Karube Y, Tanaka H, Osada H, et al. Reduced expression of DICER1 associated with poor prognosis in lung cancer patients. Cancer Sci. 2005;96:111-5.
6. Bartel DP. MicroRNAs: genomics DP, biogenesis, mechanism, function. Cell. 2004;116:281-97.
7. Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J, Kirsch DG, Golub TR, Jacks T. Dicer1 functions as a haploinsufficient tumosuppressor. Genes Dev. 2009;23:2700-4.
8. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857-66.
9. Yang C, Cai J, Wang Q, Tang H, Cao J, Liying W, Wang Z. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. Gynecol Oncol. 2012;124:325-34.
10. Abu-Rustum NR, Zhou Q, Iasonos A, Alektiar KM, et al. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer. 2010;21:511-6.
11. Gregory PA, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1. Nat Cell Biol. 2008;10:593-601.
12. Kim BH, Hong SW, Kim A, Choi SH, Yoon SO. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol. 2012. doi: 10.1002/jso.23271.
13. Ferraz C, Lorenz S, Wojtas B, Bornstein SR, Paschke R, Eszlinger M. Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis. J Clin Endocrinol Metab. 2013; 98(1):E8-E16.
14. Lai KW, Koh KX, Loh M. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer. 2010;46:1456-63.
15. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39(5):673-7.
16. Karube Y, Tanaka H, Osada H. Reduced expression of DICER1 associated with poor prognosis in lung cancer patients. Cancer Sci. 2005;96:111-5.
17. Kawase-Koga Y, Low R, Otaegi G, Pollock A, et al. RNAase-III enzyme DICER1 maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells. J Cell Sci. 2010;123:586-94.
18. Zhang L, et al. DICER1 ablation impairs prostate stem cell activity and causes prostate atrophy. Stem Cells. 2010;28(7):1260-9.
19. Suárez Y, Fernandez-Hernando C, Pober JS, Sessa WC. DICER1 dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res. 2007;100:1164-73.
20. Aglund K, Rauvala M, Puistola U, Angstrom T, TurpeenniemiHujanen T, Zackrisson B, Stendahl U. Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol. 2004;94:699-704.
21. Filipowicz W, Bhattacharyya SN, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;9:102-114.